[EN] TETRAHYDROPYRAN-4-YLETHYLAMINO- OR TETRAHYDROPYRANYL-4-ETHYLOXY-PYRIMIDINES OR -PYRIDAZINES AS ISOPRENYLCYSTEINCARBOXYMETHYL TRANSFERASE INHIBITORS<br/>[FR] PYRIMIDINES OU PYRIDAZINES TÉTRAHYDROPYRAN-4-YLÉTHYLAMINO- OU TÉTRAHYDROPYRANYL-4-ÉTHYLOXY UTILES COMME INHIBITEURS DE L'ISOPRÉNYL-CYSTÉINE-CARBOXY-MÉTHYL-TRANSFÉRASE
申请人:CANCER THERAPEUTICS CRC PTY LTD
公开号:WO2014041349A1
公开(公告)日:2014-03-20
A compound of formula (I): wherein: R1 is selected from: (i) phenyl, optionally substituted by one fluoro group; (ii) thienyl; (iii) furanyl; (iv) C1-4 alkyl; and (v) H; R2 is selected from: (II), R3 is selected from: (III), X is selected from NH and O; R4 is selected from phenyl, a 5-membered heteroaryl or a 6-membered heteroaryl, all of which are optionally substituted by one or more substituents selected from the group consisting of: methyl, methoxy, trifluoromethyl, trifluoromethoxy, cyano, fluoro, -OC2H4OMe, and pyrazolyl.
化合物的结构式(I):其中:R1选自:(i)苯基,可选择一个氟原子取代;(ii)噻吩基;(iii)呋喃基;(iv)C1-4烷基;和(v)氢;R2选自:(II),R3选自:(III),X选自NH和O;R4选自苯基,5-成员杂环基或6-成员杂环基,均可选择一个或多个取代基,所述取代基选自:甲基,甲氧基,三氟甲基,三氟甲氧基,氰基,氟原子,-OC2H4OMe和吡唑基。